Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Casonato

Showing results (21-30 of 115) with videos related to

Pageof 12
Sort By:
Arzneimittel-Forschung|January 1, 1979
The effect of certain antiplatelet drugs on in vitro malonylaldehyde (MDA) productionF Fabris, A Casonato, L De Marco, et al.
Thrombosis and Haemostasis|August 28, 1981
The effect of anticoagulant mixtures on BTG and PF4 levelsM L Randi, F Fabris, A Casonato, et al.
Blut|July 1, 1987
Discrepancies between von Willebrand factor multimeric composition and other tests in some von Willebrand's disease variantsA Casonato, F Fabris, L De Marco, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1977
Platelet adhesiveness and aggregation in combined factor V and factor VIII deficiency and in combined factor VII and factor VIII deficiencyA Girolami, L de Marco, F Fabris, et al.
Thrombosis and Haemostasis|December 27, 1982
Platelet serotonin and platelet aggregation in the differential diagnosis of thrombocytosisF Fabris, M Randi, A Casonato, et al.
Thrombosis and Haemostasis|July 15, 1999
Which assay is the most suitable to investigate von Willebrand factor functional activity?A Casonato, E Pontara, A Bertomoro, et al.
Thrombosis and Haemostasis|August 13, 1990
1-Desamino-8-D-arginine vasopressin (DDAVP) infusion in type IIB von Willebrand's disease: shortening of bleeding time and induction of a variable pseudothrombocytopeniaA Casonato, M T Sartori, L de Marco, et al.
American Journal of Clinical Pathology|March 12, 1998
The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implicationsA Casonato, E Pontara, P Zerbinati, et al.
Blut|November 1, 1981
The possible value of platelet aggregation studies in patients with increased platelet numberF Fabris, M Randi, R Sbrojavacca, et al.
Thrombosis Research|December 13, 2000
Adrenaline potentiates type 2B von Willebrand factor-induced activation of human platelets by enhancing both the formation and action of thromboxanesM Francesconi, M Scapin, A Casonato, et al.
Pageof 12

Showing results (21-30 of 115) with videos related to

Sort By:
Pageof 12
Arzneimittel-Forschung|January 1, 1979
The effect of certain antiplatelet drugs on in vitro malonylaldehyde (MDA) productionF Fabris, A Casonato, L De Marco, et al.
Thrombosis and Haemostasis|August 28, 1981
The effect of anticoagulant mixtures on BTG and PF4 levelsM L Randi, F Fabris, A Casonato, et al.
Blut|July 1, 1987
Discrepancies between von Willebrand factor multimeric composition and other tests in some von Willebrand's disease variantsA Casonato, F Fabris, L De Marco, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1977
Platelet adhesiveness and aggregation in combined factor V and factor VIII deficiency and in combined factor VII and factor VIII deficiencyA Girolami, L de Marco, F Fabris, et al.
Thrombosis and Haemostasis|December 27, 1982
Platelet serotonin and platelet aggregation in the differential diagnosis of thrombocytosisF Fabris, M Randi, A Casonato, et al.
Thrombosis and Haemostasis|July 15, 1999
Which assay is the most suitable to investigate von Willebrand factor functional activity?A Casonato, E Pontara, A Bertomoro, et al.
Thrombosis and Haemostasis|August 13, 1990
1-Desamino-8-D-arginine vasopressin (DDAVP) infusion in type IIB von Willebrand's disease: shortening of bleeding time and induction of a variable pseudothrombocytopeniaA Casonato, M T Sartori, L de Marco, et al.
American Journal of Clinical Pathology|March 12, 1998
The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implicationsA Casonato, E Pontara, P Zerbinati, et al.
Blut|November 1, 1981
The possible value of platelet aggregation studies in patients with increased platelet numberF Fabris, M Randi, R Sbrojavacca, et al.
Thrombosis Research|December 13, 2000
Adrenaline potentiates type 2B von Willebrand factor-induced activation of human platelets by enhancing both the formation and action of thromboxanesM Francesconi, M Scapin, A Casonato, et al.
Pageof 12